We are live on ! Find out more
TOIIW

The Oncology Institute Warrant

Delisted

TOIIW was delisted on the 31st of July, 2026.

14 hedge funds and large institutions have $132K invested in The Oncology Institute Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.33% less ownership

Funds ownership: 6.15%5.82% (-0.33%)

7% less funds holding

Funds holding: 1514 (-1)

90% less capital invested

Capital invested by funds: $1.3M → $132K (-$1.16M)

Holders
14
Holders Change
-1
Holders Change %
-6.67%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
5
Reduced
1
Closed
1
Calls
$5K
Puts
Net Calls
+$5K
Net Calls Change
-$5K

TOIIW Hedge Fund Activity: Q2 2023 in Review

14 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute Warrant (TOIIW) for Q2 2023, worth a combined $132K — down 90% from $1.3M a quarter earlier.

Fund positioning in TOIIW was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was Man Group, opening a new position worth an estimated $5.21K. The largest seller was Difesa Capital Management, cutting an estimated $1.83K.

  • 14 institutional investors held The Oncology Institute Warrant (TOIIW) as of Q2 2023, down from 15 in Q1 2023.
  • Funds reported $132K of The Oncology Institute Warrant stock for Q2 2023, down 90% quarter-over-quarter.
  • 1 fund opened new The Oncology Institute Warrant positions in Q2 2023 and 1 closed out, a net change of 0 holders.
  • The largest The Oncology Institute Warrant buyer in Q2 2023 was Man Group, an estimated $5.21K added.
  • The largest The Oncology Institute Warrant seller in Q2 2023 was Difesa Capital Management, an estimated $1.83K sold.

Based on aggregated 13F filings for Q2 2023.